ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AZN Astrazeneca Plc

12,106.00
-20.00 (-0.16%)
19 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -20.00 -0.16% 12,106.00 12,120.00 12,122.00 12,190.00 12,024.00 12,080.00 999,558 16:35:02
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.55 187.98B

SAR - AstraZeneca plc

26/01/2004 7:00am

UK Regulatory


RNS Number:6106U
Capital Group Companies Inc
23 January 2004

                                                                      FORM SAR 3

Lodge with Company Announcements Office and Newstrack, if appropriate, and the
Takeover Panel. A copy must also be sent to the company the shares of which are
acquired.

                                            Date of disclosure - 23 January 2004

   DISCLOSURE UNDER RULE 3 OF THE RULES GOVERNING SUBSTANTIAL ACQUISITIONS OF
                                SHARES ("SARs")



Date of acquisition           22 January 2004
                                                     

Acquisition in                AstraZeneca plc
                                                          


(1)  Class of voting shares             Number of shares/rights over shares     If rights over shares acquired, as
        (e.g. ordinary shares)          acquired                                opposed to the shares themselves,
                                                                                specify nature of rights
                               
        Ordinary Shares                      101,000 shares                                N/A
                                                   0 rights


(2)  Resultant total holding of voting  Resultant total holding of rights over  Total percentage
shares (and % of total voting shares in shares (and % of total voting shares in
issue)                                  issue)

        254,143,676 (15.01%)                            0 (0.00%)                         15.01%
                                                        

3)    Party making disclosure              The Capital Group Companies, Inc.



(4)  (a)   Name of person acquiring shares or rights over
           shares and, if different, beneficial owner:       The Capital Group Companies, Inc.



      (b)  Names of any other persons acting by
           agreement or understanding (see SAR 5)        N/A
                                                           



Signed, for and on behalf of the party named in (3) above
_________________________________



(Also print name of signatory)                   Liliane Corzo
                                                 



Telephone and extension number           Contact Greg Dickinson (213) 615-0469

                     ______________________________________

Note.  Under SAR 5, the holdings of and acquisitions by persons acting by
agreement or understanding must be aggregated and treated as a holding of or
acquisition by one person. Note 3 on SAR 5 requires persons who must aggregate
holdings to disclose certain disposals.

For full details of the SARs disclosure requirements, see Rules 3 and 5 of the
SARs. If in doubt, contact the Panel on Takeovers and Mergers, Monitoring
Section, Tel. No: 020 7638 0129.






                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

SADPUUQAGUPCPWW

1 Year Astrazeneca Chart

1 Year Astrazeneca Chart

1 Month Astrazeneca Chart

1 Month Astrazeneca Chart

Your Recent History

Delayed Upgrade Clock